Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.
- DOI
- 10.1016/j.xcrm.2026.102820
- Published
- 2026 Jun 16
- Container
- Cell reports. Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2026.102820,
title = {Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.},
author = {Zeng PYF and Meens J and Karimi AH and Pan H and Cecchini MJ and Jarycki L and Ryan SB and Dawson AE and Shaikh MH and Palma DA and Winquist E and Gunaratnam L and Mymryk JS and Barrett JW and Boutros PC and Ailles L and Nichols AC},
year = {2026},
journal = {Cell reports. Medicine},
doi = {10.1016/j.xcrm.2026.102820},
url = {https://doi.org/10.1016/j.xcrm.2026.102820}
}RIS
TY - JOUR TI - Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer. AU - Zeng PYF AU - Meens J AU - Karimi AH AU - Pan H AU - Cecchini MJ AU - Jarycki L AU - Ryan SB AU - Dawson AE AU - Shaikh MH AU - Palma DA AU - Winquist E AU - Gunaratnam L AU - Mymryk JS AU - Barrett JW AU - Boutros PC AU - Ailles L AU - Nichols AC PY - 2026 JO - Cell reports. Medicine DO - 10.1016/j.xcrm.2026.102820 UR - https://doi.org/10.1016/j.xcrm.2026.102820 ER -
APA
PYF, Z., J, M., AH, K., H, P., MJ, C., L, J., SB, R., AE, D., MH, S., DA, P., E, W., L, G., JS, M., JW, B., PC, B., L, A., & AC, N. (2026). Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2026.102820
Source records
- pubmed · retrieved 2026-09-26T03:30:50.212Z